Professor | Yanhui Yin | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Yanhui Yin

Contact Information

yinyanhui@bjmu.edu.cn

Language ability

English, Chinese

Province

Beijing

University/Lab Affiliation and Title	Peking University
Faculty	Basic Medical Sciences
Academic Background & Achievements	1993 - Bachelor of Medicine in English Medical Program, Norman Bethune College of Medicine 1996 - Master's Degree in Immunology, Norman Bethune College of Medicine 2001 - PhD in Immunology, Jilin University 2005 - Postdoctoral Research, Department of Immunology, Peking University Medical School
Work Experience	1999-2001 - Visiting Scholar, Tokushima University, Japan Current - Associate Professor, Department of Immunology, Peking University Medical School
Awards	2008 - Outstanding Young Scholar, Peking University Medical School National Education Ministry Natural Science Award, First Prize Chinese Medical Science and Technology Award, Second Prize Beijing Science and Technology Award, Second Prize

University/Lab Affiliation and Title

Peking University

Faculty

Basic Medical Sciences

Academic Background & Achievements

1993 - Bachelor of Medicine in English Medical Program, Norman Bethune College of Medicine
1996 - Master's Degree in Immunology, Norman Bethune College of Medicine
2001 - PhD in Immunology, Jilin University
2005 - Postdoctoral Research, Department of Immunology, Peking University Medical School

Work Experience

1999-2001 - Visiting Scholar, Tokushima University, Japan
Current - Associate Professor, Department of Immunology, Peking University Medical School

Awards

Areas of Focus	Immunotherapy for cancer Role and mechanisms of tumor antigens in tumor microenvironment
Publications	Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells, Yanhui Yin, 2018 Cancer-testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cells, Yanhui Yin, 2018 The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling, Yanhui Yin, 2017 Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells, Yanhui Yin, 2016 MicroRNA-874 functions as a tumor suppressor by targeting cancer/testis antigen HCA587/MAGE-C2, Yanhui Yin, 2016 Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E, Yanhui Yin, 2015 Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma, Yanhui Yin, 2015 Evaluation of KF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma, Yanhui Yin, 2015 Cancer-testis antigen HCA587/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin-proteasome pathway, Yanhui Yin, 2014 Cancer/Testis antigen HCA587-derived long peptide vaccine generates potent immunologic responses and antitumor effects in mouse model, Yanhui Yin, 2014

Areas of Focus

Immunotherapy for cancer
Role and mechanisms of tumor antigens in tumor microenvironment

Publications

Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells, Yanhui Yin*, 2018
Cancer-testis antigen HCA587/MAGEC2 interacts with the general transcription coactivator TAF9 in cancer cells, Yanhui Yin*, 2018
The cancer/testis antigen MAGEC2 promotes amoeboid invasion of tumor cells by enhancing STAT3 signaling, Yanhui Yin*, 2017
Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells, Yanhui Yin*, 2016
MicroRNA-874 functions as a tumor suppressor by targeting cancer/testis antigen HCA587/MAGE-C2, Yanhui Yin*, 2016
Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E, Yanhui Yin*, 2015
Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma, Yanhui Yin*, 2015
Evaluation of KF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma, Yanhui Yin*, 2015
Cancer-testis antigen HCA587/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin-proteasome pathway, Yanhui Yin*, 2014
Cancer/Testis antigen HCA587-derived long peptide vaccine generates potent immunologic responses and antitumor effects in mouse model, Yanhui Yin*, 2014

Immunotherapy Cancer Tumor Antigens Microenvironment Mechanisms Cell Therapy Antigen Roles Tumor Environment Cancer Research Clinical Trials

Yang Li - Peking University

Yu Yu - Peking University

Chuanhui Han - Peking University

View All

Personal Information